BHC:NYSE
Bausch Health Companies Inc
US$8.34
arrow_downward
-0.06%(-0.0050) 1D
ኖቬም 12, 1:08:48 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BHC...
Open
US$8.36
High
US$8.43
Low
US$8.26
Mkt. cap
3.14 ቢ
Avg. vol.
3.83 ሚ
Volume
1.02 ሚ
52-wk high
US$9.04
52-wk low
US$4.33
EPS
-US$2.29
Beta
0.30
Shares outstanding
374.27 ሚ
No. of employees
20 ሺ
Open
US$8.36
High
US$8.43
Low
US$8.26
Mkt. cap
3.14 ቢ
Avg. vol.
3.83 ሚ
Volume
1.02 ሚ
52-wk high
US$9.04
52-wk low
US$4.33
EPS
-US$2.29
Beta
0.30
Shares outstanding
374.27 ሚ
No. of employees
20 ሺ
News stories
From web sources and news partners
Zacks
·
ከ3 ሰዓቶች በፊት
Here's Why Bausch Health (BHC) is a Strong Momentum Stock
Profile
Bausch Health Companies Inc. is a pharmaceutical company headquartered in Laval, Quebec, Canada, with office in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees20.3 ሺ
Founded1960
Headquartersላቫል, ኬበክ, ካናዳ
SectorHealth Care
IndustryPharmaceutical industry
Websitebauschhealth.com